Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group

Bahat, Gulistan; Yilmaz, Ozlem; Merve Oren, Meryem; Akif Karan, Mehmet; Reginster, Jean-Yves; Bruyère, Olivier; Beaudart, Charlotte

doi:10.1007/s41999-017-0003-5

Article (Scientific journals)

Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group

Bahat, Gulistan; Yilmaz, Ozlem; Merve Oren, Meryem et al.

2018 • In European Geriatric Medicine, 9, p. 23-28

Peer reviewed

Permalink
https://hdl.handle.net/2268/220616

DOI
10.1007/s41999-017-0003-5

PubMed
34654275

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Cross-cultural adaptation and validation of the SARC-F_BAHAT et al EGM2017.pdf

Publisher postprint (3.8 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Sarcopenia; Screening; SARC F; Validation; Methodology

Abstract :

[en] Sarcopenia is a well-identified process of aging known to cause functional deterioration, falls, fractures, frailty and mortality. Considering the global aging population, sarcopenia assessment has become a public health priority because its early detection is expected to prevent or decrease adverse outcomes through commencement of therapeutic measures. Therefore, the diagnosis of sarcopenia mediated by effective screening is expected to become particularly important. Being very practical with clearly demonstrated value to predict sarcopenia-related adverse outcomes, SARC-F questionnaire stands as one of the best tools to evaluate sarcopenia in every day practice. SARC-F has originally been created in English. Considering the variety of languages in Europe, it seems very valid to adapt and validate this tool in different European languages. This report is written to explain the details of the final consensus methodology suggested for SARC-F validation, thereby guiding and helping the research teams in their studies.

Disciplines :

General & internal medicine
Public health, health care sciences & services

Author, co-author :

Bahat, Gulistan

Yilmaz, Ozlem

Merve Oren, Meryem

Akif Karan, Mehmet

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Beaudart, Charlotte ; Université de Liège - ULiège > Département des sciences de la santé publique > Epidémiologie clinique

Language :

English

Title :

Cross-cultural adaptation and validation of the SARC-F to assess sarcopenia: methodological report from European Union Geriatric Medicine Society Sarcopenia Special Interest Group

Publication date :

2018

Journal title :

European Geriatric Medicine

ISSN :

1878-7649

eISSN :

1878-7657

Publisher :

Elsevier Masson, France

Volume :

Pages :

23-28

Peer reviewed :

Peer reviewed

Available on ORBi :

since 21 February 2018

Statistics

Number of views

236 (12 by ULiège)

Number of downloads

4 (4 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O (2017) Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 12:e0169548. https://doi.org/10.1371/journal.pone.0169548
Beaudart C, Dawson A, Shaw SC, Harvey NC, Kanis JA, Binkley N et al (2017) Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int 28:1817–1833. https://doi.org/10.1007/s00198-017-3980-9
Cruz-Jentoft AJ, Landi F, Schneider SM, Zúñiga C, Arai H, Boirie Y et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43:748–759. https://doi.org/10.1093/ageing/afu115
Smith GI, Julliand S, Reeds DN, Sinacore DR, Klein S, Mittendorfer B (2015) Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr 102:115–122. https://doi.org/10.3945/ajcn.114.105833
Molfino A, Gioia G, Fanelli FR, Muscaritoli M (2013) Beta-hydroxy-beta-methylbutyrate supplementation in health and disease: a systematic review of randomized trials. Amino Acids 45:1273–1292. https://doi.org/10.1007/s00726-013-1592-z
Devries MC, Phillips SM (2014) Creatine supplementation during resistance training in older adults-a meta-analysis. Med Sci Sports Exerc 46:1194–1203. https://doi.org/10.1249/MSS.0000000000000220
Morley JE (2016) Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 98:319–333. https://doi.org/10.1007/s00223-015-0022-5
Drescher C, Konishi M, Ebner N, Springer J (2015) Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment. J Cachexia Sarcopenia Muscle 6:303–311. https://doi.org/10.1002/jcsm.12082
Molfino A, Amabile MI, Fanelli FR, Muscaritoli M (2016) Novel therapeutic options for cachexia and sarcopenia. Expert Opin Biol Ther. 16:1239–1244. https://doi.org/10.1080/14712598.2016.1208168
Malmstrom TK, Morley JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14:531–532. https://doi.org/10.1016/j.jamda.2013.05.018
Ethgen O, Beaudart C, Buckinx F, Bruyère O, Reginster JY (2017) The future prevalence of sarcopenia in Europe: a claim for public health action. Calcif Tissue Int 100:229–234. https://doi.org/10.1007/s00223-016-0220-9
Tan LF, Lim ZY, Choe R, Seetharaman S, Merchant R (2017) Screening for frailty and sarcopenia among older persons in medical outpatient clinics and its associations with healthcare burden. J Am Med Dir Assoc 24:583–587. https://doi.org/10.1016/j.jamda.2017.01.004
Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R et al (2016) Sarcopenia in daily practice: assessment and management. BMC Geriatr 16:170. https://doi.org/10.1186/s12877-016-0349-4
Morley JE (2016) Frailty and sarcopenia in elderly. Wien Klin Wochenschr 128:439–445
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423. https://doi.org/10.1093/ageing/afq034
Fielding RA, Vellas B, Evans WJ, Bhanis S, Morley JE, Newman AB et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12:249–256. https://doi.org/10.1016/j.jamda.2011.01.003
Dam TT, Peters KW, Fragala M, Cawthon PM, Harris TB, McLean R et al (2014) An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol Ser Biol Sci Med Sci 69(5):584–590. https://doi.org/10.1093/gerona/glu01316
Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S et al (2011) Society on sarcopenia, cachexia and wasting disorders trialist workshop. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12:403–409. https://doi.org/10.1016/j.jamda.2011.04.014
Parra-Rodríguez L, Szlejf C, García-González AI, Malmstrom TK, Cruz-Arenas E, Rosas-Carrasco O (2016) Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults. J Am Med Dir Assoc 17:1142–1146. https://doi.org/10.1016/j.jamda.2016.09.008
Ida S, Murata K, Nakadachi D, Ishihara Y, Imataka K, Uchida A et al (2016) Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity. Aging Clin Exp Res 1:8
Barbosa-Silva TG, Menezes AM, Bielemann RM, Malmstrom TK, Gonzalez MC, Grupo de Estudos em Composição Corporal e Nutrição (COCONUT) (2016) Enhancing SARC-F: improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc 17:1136–1141. https://doi.org/10.1016/j.jamda.2016.08.004
Kemmler W, Sieber C, Freiberger E, von Stengel S (2017) The SARC-F Questionnaire: Diagnostic Overlap with Established Sarcopenia Definitions in Older German Men with Sarcopenia. Gerontology 63(5):411–416
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE (2016) SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7:28–36. https://doi.org/10.1002/jcsm.12048
Woo J, Leung J, Morley JE (2014) Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 15:630–634. https://doi.org/10.1016/j.jamda.2014.04.021
Liccini A, Malmstrom TK (2016) Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus. J Am Med Dir Assoc 17:846–851. https://doi.org/10.1016/j.jamda.2016.07.007
WHO (2010) Process of translation and adaptation of instruments: World Health Organization. http://www.who.int/substance_abuse/research_tools/translation/en/. Accessed 11 May 2010
Naghdi S, Ansari NN, Ashrafi H, Entezary E, Ansari AN, Olyaei G (2015) Cross-cultural adaptation of the Micheli functional scale to Persian language for evaluation of low back pain in the young athletes. Asian J Sports Med 6:e26839. https://doi.org/10.5812/asjsm.26839
Kaka B, Ogwumike OO, Idowu OA, Odole AC, Saidu AM, Fawole HO et al (2015) Translation of the fear avoidance beliefs questionnaire into Hausa language. Glob J Health Sci 7:116–123. https://doi.org/10.5539/gjhs.v7n3p116
Soares JB, Pereira R, Costa JM, Arroja B, Goncalves R (2016) The Inflammatory Bowel Disease-Disability Index: validation of the Portuguese version according to the COSMIN checklist. Eur J Gastroenterol Hepatol 28:1151–1160. https://doi.org/10.1097/MEG.0000000000000701
Wang SL, Wu B, Leng L, Bucala R, Lu LJ (2013) Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus. PLoS One 8:e63795. https://doi.org/10.1371/journal.pone.0063795
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383. https://doi.org/10.1016/0021-9681(87)90171-8
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW (1963) Studies of illness in the aged. The Index of Adl: a standardized measure of biological and psychosocial function. JAMA 185:914–919. https://doi.org/10.1001/jama.1963.03060120024016
Lawton MP, Brody EM (1969) Assessment of older people: self-management. Gerontologist 9:179–186
Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. J Ann Med 33:337–343. https://doi.org/10.3109/07853890109002087
Guigoz Y, Vellas B, Garry PJ (1996) Assessing the nutritional status of the elderly: the mini nutritional assessment as part of the geriatric evaluation. Nutr Rev 54:59–65
McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med 22:276–282
Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155–163. https://doi.org/10.1016/j.jcm.2016.02.012
Nunnally JC, Bernstein I (1994) Psychometric theory, 3rd edn. McGrawHill Inc, New York